Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction

Abstract Aims Besides regulating calcium‐phosphate metabolism, fibroblast growth factor 23 (FGF‐23) has been associated with incident heart failure (HF) and left ventricular hypertrophy. However, data about FGF‐23 in HF and preserved ejection fraction (HFpEF) remain limited. The aim of this study wa...

Full description

Bibliographic Details
Main Authors: Clotilde Roy, Sibille Lejeune, Alisson Slimani, Christophe deMeester, Sylvie A. Ahn AS, Michel F. Rousseau, Amzulescu Mihaela, Audrey Ginion, Benjamin Ferracin, Agnès Pasquet, David Vancraeynest, Christophe Beauloye, Jean‐Louis Vanoverschelde, Sandrine Horman, Damien Gruson, Bernhard L. Gerber, Anne‐Catherine Pouleur
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:ESC Heart Failure
Subjects:
FGF‐23
Biomarker
Troponin
Mortality
NT‐proBNP
Heart failure
Online Access:https://doi.org/10.1002/ehf2.12816

Internet

https://doi.org/10.1002/ehf2.12816

Similar Items